US 2014/0212514 A1Published application

Prevention of gastric ulcer by carbon monoxide

AssigneeALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda.

InventorsSandra Sofia Pereira Rodrigues, Joaõ D. Seixas, Bruno Guerreiro, Nuno Miguel Penacho Pereira, Carlos C. Romão, Werner E. Haas, Isabel Goncalves

Life of this patent

Estimating the term…

Abstract

The invention relates to the use of carbon monoxide (CO) to inhibit the gastrointestinal side effects caused by non-steroidal anti-inflammatory drugs (NSAIDs) and/or alcohol.

Claims11

Dependent claims

-43. (canceled)

Dependencies are inferred from the claim text.

Facts

Application: 14/052,551Filed 11 Oct 2013
Priority: 24 Jul 2007
Published: 31 Jul 2014
Term ends: Not estimatedThe source records don’t support an estimate.

Classification12 codes

A61K 33/00
Medicinal preparations containing inorganic active ingredients
A61K 9/0053
Galenical forms characterised by the site of application: mouth and digestive tract, i.e. intraoral and peroral administration
A61K 9/08
Medicinal preparations characterised by special physical form: solutions
A61K 31/405
Indoles, e.g. pindolol: indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin

Family

Application60/951,650Us provisional application · filed 24 Jul 2007
Application12/670,466Continuation · filed 29 Oct 2010
Application14/052,551Continuation
US 2011/0038955 A1Published application
US 2014/0212514 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results